ArticlePharmaceuticals (Basel, Switzerland)2023

Drug Repurposing of FDA Compounds against α-Glucosidase for the Treatment of Type 2 Diabetes: Insights from Molecular Docking and Molecular Dynamics Simulations.

Rebwar Saeed M Rashid et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.